Discover innovative solutions to the key challenges of the drug safety industry
Ronald Leong | Executive Director, Patient Safety USA AstraZeneca Pharmaceuticals
Ronald W. Leong, MD, Executive Director, US Patient Safety, AstraZeneca, has 24 years of experience in the pharmaceutical industry. He has worked at Upjohn, Proctor & Gamble, Wyeth and AstraZeneca, where he has been employed since 2002. His experience includes Clinical Development, U.S. regulatory affairs and both U.S. and international Drug Safety. Dr. Leong represents AstraZeneca on PhRMA and BIO working groups relating to Pharmacovigilance. He earned his A.B. and M.D. degrees at Washington University of St. Louis, U.S. and completed a residency in Internal Medicine. Dr. Leong is board certified in Internal Medicine and practiced medicine prior to entering the pharmaceutical industry.
Share this
Appearances at this years' conference:
Day one AM - Wednesday 18th April 2012
@ 09.15
Panel session- Is there a lack of regulatory transparency in the pharma industry?
• Ensuring pharma understand the regulations and the resulting requirements
› Ronald Leong, Executive Director, Patient Safety USA, AstraZeneca Pharmaceuticals
Day one- STREAM 2: SAFETY DATA MANAGEMENT
@ 14.15
Sentinel: perspective of a non-epidemiologist
Updates on Sentinel and Mini-sentinel
Implications for overall safety profile and labelling
› Ronald Leong, Executive Director, Patient Safety USA, AstraZeneca Pharmaceuticals